ISA Pharmaceuticals announce new trial testing technology for cancers
Trial of Amplivant will begin in a number of cancer patients including those with ovarian cancer
Read More
Author: John Pinching
Ampersand Health and UCB partner in new arthritis initiative
Companies will support a study which provides vital information on arthritis for patient-supporting HCPs
Read More
Cannabis firm launches UK clinic following prescription license allocation
Cantourage has appointed cannabis prescribers and is now officially operational via a new centre
Read More
Engetix and Takeda announce expanded collaboration for anti-fibrotic therapies
Engitix and Takeda will extend existing agreement to collaborate extensively in the development of therapeutics in IBD
Read More
Novacyt PCR COVID-19 test approved under CTDA legislation
Novacyt’s second direct-to-PCR test is the third product to be added to the Coronavirus Test Device Approvals (CTDA) register of approved products
Read More- Pierre Fabre Laboratories secures CHMP backing for first‑line BRAFTOVI regimen
- Resolution Therapeutics hails positive 4‑year MATCH data in liver cirrhosis
- KOALA trial opens to enrol patients for first‑in‑human KMCAR T‑cell therapy
- Pepaxti study supports use in wider myeloma population
- UCB reports positive outcomes for bimekizumab in psoriatic arthritis
